Addus HomeCare (NASDAQ:ADUS) Receives Hold (C+) Rating from Weiss Ratings

Key Points

• Addus HomeCare's stock has received a "hold (C+)" rating from Weiss Ratings, reflecting cautious sentiment among analysts.
• Barclays and Royal Bank of Canada have recently raised their target prices for Addus HomeCare, with Barclays setting it at $109 and RBC at $134, indicating varied outlooks on the stock.
• In recent transactions, key executives, including the CEO, have sold significant shares of the company's stock, suggesting potential insider sentiment regarding future performance.

Addus HomeCare (NASDAQ:ADUS - Get Free Report)'s stock had its "hold (c+)" rating reaffirmed by investment analysts at Weiss Ratings in a research note issued to investors on Friday,Weiss Ratings reports.

Several other research firms have also recently commented on ADUS. Barclays raised their target price on shares of Addus HomeCare from $83.00 to $109.00 and gave the stock an "underweight" rating in a research report on Tuesday, August 19th. Royal Bank Of Canada raised their target price on shares of Addus HomeCare from $133.00 to $134.00 and gave the stock an "outperform" rating in a research report on Friday, August 22nd. Wall Street Zen raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Sunday, June 29th. JMP Securities reissued a "market outperform" rating and set a $150.00 price target on shares of Addus HomeCare in a research report on Wednesday, July 16th. Finally, TD Cowen lifted their price target on shares of Addus HomeCare from $135.00 to $139.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $137.50.

Addus HomeCare Trading Up 1.6%

Addus HomeCare stock traded up $1.88 during trading hours on Friday, reaching $122.56. The stock had a trading volume of 21,566 shares, compared to its average volume of 179,806. The company has a fifty day simple moving average of $114.70 and a 200-day simple moving average of $111.11. Addus HomeCare has a 52 week low of $88.96 and a 52 week high of $136.72. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.74 and a quick ratio of 1.74. The stock has a market cap of $2.26 billion, a PE ratio of 27.08, a PEG ratio of 1.85 and a beta of 0.86.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Monday, August 4th. The company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.45 by $0.04. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The firm had revenue of $349.44 million during the quarter, compared to analysts' expectations of $345.71 million. During the same period last year, the company posted $1.35 EPS. The company's quarterly revenue was up 21.8% compared to the same quarter last year. Analysts forecast that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Insiders Place Their Bets

In other Addus HomeCare news, EVP Brian Poff sold 7,739 shares of Addus HomeCare stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $116.82, for a total value of $904,069.98. Following the completion of the transaction, the executive vice president directly owned 56,980 shares of the company's stock, valued at approximately $6,656,403.60. The trade was a 11.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO R Dirk Allison sold 25,000 shares of the business's stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $114.95, for a total value of $2,873,750.00. Following the completion of the transaction, the chief executive officer owned 166,461 shares of the company's stock, valued at $19,134,691.95. This represents a 13.06% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 34,310 shares of company stock valued at $3,958,375. Insiders own 4.50% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. State of Wyoming purchased a new position in shares of Addus HomeCare during the second quarter valued at approximately $47,000. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in Addus HomeCare during the first quarter valued at approximately $41,000. Raymond James Financial Inc. purchased a new stake in Addus HomeCare during the second quarter valued at approximately $61,000. Blue Trust Inc. boosted its position in shares of Addus HomeCare by 42.9% in the third quarter. Blue Trust Inc. now owns 536 shares of the company's stock worth $63,000 after purchasing an additional 161 shares during the period. Finally, CWM LLC boosted its position in shares of Addus HomeCare by 25.3% in the second quarter. CWM LLC now owns 554 shares of the company's stock worth $64,000 after purchasing an additional 112 shares during the period. Hedge funds and other institutional investors own 95.35% of the company's stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.